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TEF1are likely to play multiple, integral roles during replication of plus-strand RNA
viruses. To identify host proteins that bind to viral RNAs, we took a global approach based on the yeast
proteome microarray, which contains 4080 puriﬁed yeast proteins. The biotin-labeled RNA probes included
two distantly related RNA viruses, namely Tomato bushy stunt virus (TBSV) and Brome mosaic virus (BMV).
Altogether, we have identiﬁed 57 yeast proteins that bound to TBSV RNA and/or BMV RNA. Among the
identiﬁed host proteins, eleven bound to TBSV RNA and seven bound to BMV RNA with high selectivity,
whereas the remaining 39 host proteins bound to both viral RNAs. The interaction between the TBSV replicon
RNA and ﬁve of the identiﬁed host proteins was conﬁrmed via gel-mobility shift and co-puriﬁcation
experiments from yeast. Over-expression of the host proteins in yeast, a model host for TBSV, revealed 4 host
proteins that enhanced TBSV replication as well as 14 proteins that inhibited replication. Detailed analysis of
one of the identiﬁed yeast proteins binding to TBSV RNA, namely translation elongation factor eEF1A,
revealed that it is present in the highly puriﬁed tombusvirus replicase complex. We also demonstrate binding
of eEF1A to the p33 replication protein and a known cis-acting element at the 3′ end of TBSV RNA. Using a
functional mutant of eEF1A, we provide evidence on the involvement of eEF1A in TBSV replication.
© 2008 Published by Elsevier Inc.IntroductionPlus-stranded (+)RNA viruses, the largest group among viruses,
contain relatively small genomes and thus greatly depend on the
infected hosts in many steps during their infection cycles. Indeed,
viruses are known to recruit numerous host proteins to facilitate their
replication and spread (Ahlquist et al., 2003; Nagy, 2008; Noueiry and
Ahlquist, 2003). Several host RNA-binding proteins have been
implicated in replication of (+)RNA viruses, including ribosomal
proteins, translation factors and RNA-modifying enzymes (Ahlquist
et al., 2003; Buck,1996,1999; Nagy, 2008; Noueiry and Ahlquist, 2003;
Strauss and Strauss, 1999; Wang and Nagy, 2008). In addition, recent
genome-wide screens of yeast genes conducted with two distantly
related viruses, Brome mosaic virus (BMV) (Kushner et al., 2003) and
Tomato bushy stunt virus (TBSV) (Jiang et al., 2006; Panavas et al.,
2005b) revealed that their replication is affected by ∼100 different
host genes. The genome-wide screens with TBSV also identiﬁed ∼30
host genes affecting TBSV RNA recombination (Cheng et al., 2006;
Serviene et al., 2006, 2005). The identiﬁed host genes code for
proteins involved in various cellular processes, such as translation,lsevier Inc.RNA metabolism, protein modiﬁcations and intracellular transport or
membrane modiﬁcations (Jiang et al., 2006; Kushner et al., 2003;
Panavas et al., 2005b). Additional genome-wide screens with Droso-
phila virus C and West Nile virus have also identiﬁed over 100 host
genes (Cherry et al., 2005; Krishnan et al., 2008). However, these
genome-wide screens likely missed the identiﬁcation of host genes
with overlapping functions. Therefore, additional screens are needed,
which are less affected by gene redundancy, to identify the total
number of host genes affecting virus replication.
One of the major groups of host factors that likely affect RNA virus
replication is RNA-binding proteins that play essential roles in many
cellular processes, such as transcription, splicing, translation, mRNA
turnover, and antiviral mechanisms. These protein–RNA interactions
affect the structures and functions of abundant ribonucleoprotein
complexes, which contain many different proteins and RNAs. Thus,
subverting some RNA-binding proteins could be beneﬁcial for
facilitating replication of RNA viruses.
TBSV and other tombusviruses are useful model viruses that infect
a wide range of plants. The 4.8 kb TBSV genomic (g)RNA codes for two
replication proteins, termed p33 and p92pol, and three proteins
involved in encapsidation, cell-to-cell movement and suppression of
gene silencing (Nagy and Pogany, 2008; White and Nagy, 2004).
Interestingly, yeast cells expressing p33 and p92pol replication
proteins can efﬁciently replicate a short TBSV-derived replicon (rep)
246 Z. Li et al. / Virology 385 (2009) 245–260RNA, termed defective interfering (DI) RNA (Panavas and Nagy, 2003;
Panaviene et al., 2004). The tombusviral RNA plays several functions
during infection, including serving as a template for replication and as
an assembly platform for the viral replicase complex (Nagy and
Pogany, 2008; Panaviene et al., 2005; Pogany et al., 2005). The viral or
DI RNA also participate in RNA recombination (Serviene et al., 2005;
White and Morris, 1994b; White and Nagy, 2004), which likely plays
major role in virus evolution.
To identify host proteins that interact with viral RNA, we took a
global approach based on the yeast proteome microarray (protein
array) (Zhu et al., 2001, 2003). Previous studies using the yeast protein
array have identiﬁed numerous yeast proteins involved in protein–
protein interactions, lipid binding, DNA binding and small substrate
binding, thus demonstrating the usefulness of the global analysis
approach (Hall et al., 2004; Huang et al., 2004; Smith et al., 2005; Zhu
et al., 2001, 2003). Also, the yeast protein array identiﬁed 58 yeast
proteins interacting with the TBSV p33 and an additional 11 yeast
proteins interactingwith the readthrough portion of p92pol replication
protein (Li et al., 2008). In addition, a yeast protein array approachwas
used to identify many host proteins interacting with a 3′ fragment of
the BMV RNA (Zhu et al., 2007). Two of those host proteins were found
to affect BMV infection in plants.
In the present work, we expanded the versatility of the yeast
protein array by screening for host proteins that bind to viral RNA.Fig. 1. Identiﬁcation of viral RNA-binding proteins by the yeast proteome microarray. (A) B
indicated. Three subarrays are shown at higher magniﬁcation to illustrate the binding of hos
variable amounts of yeast proteins (supplied by Invitrogen) which were used to calculate thAltogether, this work identiﬁed 57 host proteins that bound to either
TBSV or to BMV RNA or both RNAs. Eleven of the identiﬁed host
proteins that bound to the TBSV RNA included known helicases,
translation factors, and RNA modifying enzymes. Host proteins
binding to BMV RNA included tRNA binding proteins, and proteins
that are part of large mRNP complexes. More detailed work with a
TBSV RNA binding protein, namely eukaryotic translation elongation
factor 1A (eEF1A), has revealed that eEF1A is a component of the
puriﬁed replicase and binds to the 3′ end of the TBSV RNA as well as to
TBSV p33 replication co-factor. An eEF1A mutant has provided
evidence that eEF1A is important for TBSV replication by stabilizing
the p33 replication protein.
Results
Yeast protein array-based identiﬁcation of host proteins binding to TBSV
and BMV RNAs
To probe the yeast protein array for RNA-binding proteins, we
used biotinylated RNAs of two different RNA viruses, TBSV and BMV,
which can replicate in yeast (Ishikawa et al., 1997; Panavas and
Nagy, 2003). Because TBSV and BMV are only distantly related, they
provided good substrates to identify virus-speciﬁc and nonspeciﬁc
RNA-binding proteins. For example, the TBSV RNA is uncapped andiotinylated TBSV gRNA (noncapped) or (B) BMV RNA1 (capped) probes were used as
t proteins to TBSV (top), to BMV (bottom) or to both RNAs (middle). The array contains
e binding for each protein (see Table 1).
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is capped and carries a tRNA-like structure at the 3′ end (Noueiry and
Ahlquist, 2003). In the experiments involving TBSV, we used either the
full-length genomic (g)RNA or a defective interfering (DI) RNA,
whereaswe chose RNA1 of the three-component BMV for comparison.
A nonspeciﬁc unlabeled competitor, in the form of poly(dC)–poly(dG),Table 1
The name and functions of yeast proteins bound to viral RNAs
1 Genes binding speciﬁcally to either TBSV gRNA (lines at the top) or the BMV RNA 1 (lines
2 Binding of the yeast protein to TBSV RNA (second column) or BMV RNA (third column)
of the selected protein on the array)×10,000. The binding values are indicated as follows:
The values were derived from repeated experiments.
3 Relative binding to the viral RNAs was calculated by the dividing the unit value in the TBS
4 Documented effect on TBSV or BMV replication (repl) or protein–protein interaction base
Panavas et al., 2005b; Serva and Nagy, 2006; Serviene et al., 2006, 2005; Zhu et al., 2007).
5 RBP, RNA binding protein, which has documented RNA binding function based on Saccharwas used in the RNA binding solution to reduce signals derived from
nonspeciﬁc binding to the chip and to general DNA-binding proteins
(Hall et al., 2004). The biotinylated viral RNA probes bound to the
puriﬁed host proteins on the protein array (Fig. 1) were detected by
using Streptavidin-Alexa Fluor647 and a microchip scanner (see
Materials and methods).at the bottom) are shown in gray boxes.
was calculated based on the following formula: (signal−background signal /amount
++++, above 1000; ++, between 300 and 1000; +, between 50 and 300; −, below 50.
V column with that in the BMV column.
d on previous genome-wide and proteomics screens (Jiang et al., 2006; Li et al., 2008;
omyces Genome Database (http://www.yeastgenome.org/).
Fig. 2. Binding of recombinant host proteins to the TBSV (+)repRNA in vitro. Gel mobility shift assay was performed with the 32P-labeled DI-72 (+)repRNA as the probe. The
recombinant host proteins puriﬁed from E. coli asMBP fusion proteins were tested in three different dilutions: 2.0, 0.6 and 0.2 μg. The puriﬁed recombinantMBP (2.0 μg) was used as a
negative control.
Fig. 3. Co-puriﬁcation of TBSV (+)repRNA with selected yeast proteins from yeast cells.
(A) Three TAP-tagged host proteins (expressed from their native promoters and
chromosomal locations) were co-expressed with TBSV (+)repRNA in yeast, followed by
two-step TAP-afﬁnity puriﬁcation. Northern blot analysis was used to estimate the
amount of co-puriﬁed TBSV (+)repRNA present in the puriﬁed protein samples. The left
side of the panel shows (+)repRNA present after one-step puriﬁcation, whereas the
right side of the panel shows the (+)repRNA present after two-step puriﬁcation. The
ratio of the repRNA present was compared to the control sample obtained from yeast
lacking any TAP-tagged protein. (B) The puriﬁed proteins were analyzed by SDS-PAGE
and silver-staining. The expected full-length proteins are marked with arrowheads. (C)
Three GST-tagged host proteins (expressed from GAL1 promoter from expression
plasmids) were co-expressed with TBSV (+)repRNA in yeast, followed by one-step GST-
afﬁnity puriﬁcation. Northern blot analysis was used to estimate the amount of co-
puriﬁed TBSV (+)repRNA present in the puriﬁed protein samples. (D) The puriﬁed
proteins were analyzed by Western blotting using an anti-His antibody. The expected-
size proteins are marked with arrowheads.
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4080 yeast proteins present on the protein array (Table 1). Eleven of
these proteins bound to TBSV (+)RNA with at least 3-fold higher
efﬁciency than to BMV (+)RNA, whereas seven proteins bound to the
BMV RNA more selectively than to the TBSV RNA (Table 1). The
remaining 39 proteins bound to both viral RNAs to similar extents (i.e.,
showing less than a 3-fold difference in binding to either RNA). All the
identiﬁed host proteins that bound to the full-length TBSV gRNA also
bound to DI-72 (+)RNA (not shown). Fig. 1 represents data obtained
with selected host proteins that bound strongly to TBSV, BMV or both
RNAs.
In vitro binding of host proteins to TBSV repRNA
To conﬁrm the viral RNA-binding ability of the identiﬁed yeast
proteins (Table 1), we expressed 10 proteins, namely Gcd2p, Utp7p,
Deg1p, Dbp2p, Tef2p (eEF1A), Rpl8Ap, Pus4p, Has1p, YFR038W and
Sec62p, tagged with maltose binding protein (MBP) in E. coli,
followed by afﬁnity-puriﬁcation. The obtained recombinant proteins
were used in standard gel mobility shift experiments with 32P-labeled
DI-72(+) RNA probe. All these yeast proteins bound to DI-72(+) RNA
probe in vitro (Fig. 2 and data not shown), conﬁrming that the
identiﬁed yeast proteins can bind to TBSV RNA. Note that Deg1p and
Pus4p bound to the (+)repRNA much better in the standard replicase
buffer (Nagy and Pogany, 2000) based on similar gel mobility shift
assay (not shown).
Co-puriﬁcation of selected yeast proteins with TBSV RNA from yeast
To demonstrate that some of the above identiﬁed host RNA-
binding proteins can also bind to the tombusviral RNA in yeast cells,
we selected ﬁve yeast proteins for follow-up experiments. These
proteins included Deg1p pseudouridine synthase, Dbp2p RNA heli-
case, Gcd2p translation initiation factor, Tef2p, called translation
elongation factor 1A (eEF1A), and Utp7p processosome component
(Table 1). While the Tef2p form of eEF1Awas utilized in these studies,
eEF1A is encoded by two genes with identical coding sequences, TEF1
and TEF2 and the protein is henceforth referred to as eEF1A. Four of
these proteins were expressed separately from their natural promoter
and chromosomal location in yeast. These proteins carried a TAP-tag
(Puig et al., 2001) to facilitate co-puriﬁcation experiments with the
expressed TBSV repRNA. We observed that Gcd2p was not expressed
in high enough level for these experiments (not shown).
After the two-step TAP-afﬁnity puriﬁcation, we found that the
TBSV (+)repRNA co-puriﬁed with three of the yeast RNA-binding
proteins (5-to-124-fold enrichment of TBSV repRNA) (Fig. 3A). The
highest extent of enrichment for TBSV repRNA was obtained with
Deg1p and Dbp2p, whereas Utp7p preparations showed ∼5-fold
repRNA enrichment (Fig. 3A). However, this difference in repRNA
enrichment might partially be due to the different levels of host
proteins recovered in these preparations. For example, Deg1p was
present in greater abundance than Dbp2p or Utp7p in the puriﬁed
preparations (Fig. 3B).
Fig. 4. The effect of over-expression of selected yeast proteins on TBSV repRNA accumulation in yeast. (A) The given host proteinwas over-expressed from the GAL1 promoter prior to
launching TBSV repRNA replication from the CUP1 promoter. The accumulation level of the plus-stranded TBSV repRNA was estimated by using Northern blotting with a TBSV-
speciﬁc probe. The data were normalized based on 18S ribosomal RNA levels. The average effect of each host protein on repRNA accumulation is shown based on 6–8 separate
samples. Host proteins in black and gray boxes stimulated and inhibited, respectively, TBSV repRNA accumulation more signiﬁcantly than over-expression of the APT2 pseudogene
(marked with asterisk). The average accumulation of TBSV repRNA in yeast carrying an empty expression vector, shown as wt, was taken as 100% (based on two sets of experiments
with total of 12 samples). (B) Western blotting analysis of over-expressed host proteins and p33 and p92 replication proteins in yeast using anti-His antibody. Note that each host
proteins carry a 19KDa C-terminal tag.
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we expressed them as GST-tagged fusion proteins from an expression
plasmid. This approach led to detectable expression of eEF1A and
Gcd2p as well as Deg1p control protein in yeast (Fig. 3D). Northern
blot analysis of the co-puriﬁed RNAs revealed enrichment for TBSV (+)
repRNA in the GST afﬁnity-puriﬁed eEF1A, Gcd2p and Deg1p
preparations when compared to the GST control preparation (Fig.
3C). Altogether, the co-puriﬁcation of the selected host proteins and
the TBSV repRNA suggests that these yeast proteins can bind to the
TBSV repRNA in yeast, verifying the usefulness of our global analysis
approach.Effect of over-expression of selected host proteins on TBSV repRNA
replication in yeast
To test if the above identiﬁed viral RNA binding proteins of yeast
could affect tombusvirus RNA replication, we over-expressed 45 host
proteins individually in yeast cells from the galactose inducible GAL1
promoter (Gelperin et al., 2005). After 20 h expression of the
particular host protein, we launched TBSV repRNA replication from
CUP1 promoter as described in the Materials and methods. Yeast
cells were harvested 24 h later, at which point the amount of viral
repRNA was assessed by Northern blotting and compared with yeast
Fig. 6. Interaction between eEF1A and p33 in the split-ubiquitin two-hybrid assay. The
full-length TEF2 sequence was fused to NubG as N-terminal fusion, and the p33
sequence was fused to Cub. The heat shock protein 70 (SSA1) was used as a positive
control because it is known to interact with p33 (Serva and Nagy, 2006).
Fig. 5. Co-puriﬁcation of eEF1A with the tombusvirus replicase from yeast. (A) The
membrane-enriched fraction of yeast expressing the FLAG/6xHis-tagged p33HF/p92HF
(+) (lanes 2, 4 and 6) or the 6xHis-tagged p33H/p92H (−, lanes 1, 3 and 5) was solubilized
andwas sequentially puriﬁed onNi-afﬁnity and FLAG-afﬁnity columns.Western-blotting
with anti-6xHis antibodydetected thepresence of p33 andp92pol in thepuriﬁed replicase
complex that is active in an in vitro replication assay (not shown) as demonstrated earlier
(Serva andNagy, 2006). The asterisks indicatep33 homodimers that are partly resistant to
denaturing conditions. Yeast cellswere subjected to formaldehyde cross-linking (lanes 3–
6) prior to lysis, puriﬁcation and digestionwith RNase A (lanes 5–6) (B)Western blotting
of the same samples as in panel A with anti-eEF1A antibody. Note that the native eEF1A
was expressed from its original promoter and original location on the chromosome.
(C) The original amount of eEF1A in solubilized membrane preparations from yeast was
detected with anti-eEF1A antibody in total protein samples.
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experiments revealed that over-expression of four host proteins,
Dbp2p, Gcd2p, Mdm38p and Stm1p, increased repRNA accumulation
by, 35, 59, 55 and 43%, respectively, when compared to yeast carrying
the empty expression vector (Fig. 4A). In contrast, over-expression of
14 viral RNA-binding proteins highlighted in gray reduced TBSV
repRNA accumulation by 2.5-to-10-fold in yeast (Figs. 4A, B). Over-
expression of the remaining 28 host proteins inhibited TBSV repRNA
accumulation by two-fold or less (Fig. 4A). This level of inhibition of
TBSV repRNA accumulation might not be signiﬁcant, because over-
expression of a pseudogene (APT2), which has no enzymatic activity
when expressed (Alfonzo et al., 1999), also led to reduced TBSV
repRNA accumulation (63.7±15.9%), suggesting that two-fold or less
reduction might be due to the reduced ability of yeast cells to support
repRNA accumulation under the protein over-expression condition.
Together, the above experiments indicated that over-expression of
∼40% of the 45 RNA-binding host proteins could affect TBSV repRNA
accumulation in yeast.
eEF1A is a component of the puriﬁed tombusvirus replicase
To further test the functional relevance of the identiﬁed yeast
proteins interacting with the TBSV repRNA, we selected eEF1A, which
functions as a translation elongation factor and has been shown to be
part of replicase complexes of several RNA viruses (Blackwell and
Brinton, 1997; Blumenthal et al., 1976; Brinton, 2001; Nishikiori et al.,
2006) and its ability to bind to the tombusvirus p92 RdRp protein (Li et
al., 2008). In addition, we performed preliminary pull-down experi-
ments with biotin-labeled DI-72 (+)repRNA that was immobilized
onto the streptavidin coated magnetic beads, followed by binding
assay using a yeast cytosolic extract (Pogany and Nagy, 2008), which
have led to the identiﬁcation of eEF1A by mass-spectrometry (not
shown). This ﬁnding suggested that eEF1A is likely one of the major
TBSV RNA binding proteins in the yeast cytosol. To test if eEF1A is acomponent of the tombusvirus replicase complex, we used a eEF1A-
speciﬁc antibody in Western blotting of a highly puriﬁed replicase
preparation that was obtained via two-step Nickel/FLAG-afﬁnity
puriﬁcation of the solubilized tombusviral p33HF and p92HF proteins
tagged with 6xHis- and FLAG afﬁnity tags from enriched membranes
derived from yeast (Li et al., 2008). eEF1A was easily detectable in the
puriﬁed replicase complex, regardless of whether or not crosslinking
was applied (Fig. 5, lanes 2 and 4). Similar preparations obtained via
two-step afﬁnity puriﬁcation from yeast expressing only single 6xHis-
tagged p33H and p92H proteins contained only small amount of
eEF1A, suggesting that the presence of eEF1A in the highly puriﬁed
tombusvirus replicase preparation is not due to contamination of the
afﬁnity-resin with the abundant eEF1A (Fig. 5, lanes 1 and 3). Since
eEF1A binds to the TBSV repRNA, it is possible that these proteins are
part of the solubilized/puriﬁed replicase complex via binding to the
TBSV repRNA. This possibility was tested by treating the solubilized/
puriﬁed replicase complex with an RNase during the ﬁrst afﬁnity
puriﬁcation step to destroy the RNA components, followed by FLAG-
afﬁnity puriﬁcation. Interestingly, the amount of co-puriﬁed eEF1A
was unchanged in the highly puriﬁed replicase (Fig. 5, lane 6),
suggesting that eEF1A not only binds to the repRNA, but to a protein
component of the viral replicase as well.
To test if eEF1A can indeed interact with p33 replication cofactor,
we used the split-ubiquitin yeast two-hybrid assay, which, unlike the
original yeast two-hybrid system, allows the analysis of protein
interactions on the cytosolic surfaces of membranes where p33
protein is localized (McCartney et al., 2005; Panavas et al., 2005a).
Brieﬂy, the split-ubiquitin assay is based on the ability of N-terminal
(NubG) and C-terminal (Cub) halves of ubiquitin to reconstitute a
functional protein (Fetchko et al., 2003; Fetchko and Stagljar, 2004).
When NubG and Cub, which are fused separately to interacting
proteins, are brought to close proximity and reconstitute a functional
ubiquitin protein, then cleavage by endogenous ubiquitin speciﬁc
proteases leads to the release of the transcription factor, resulting in
growth on selective media. The split ubiquitin assay revealed that
eEF1A interacted with the membrane-bound p33 when used as N-
terminal fusionwith NubG (Fig. 6) indicating that eEF1A interacts with
both the TBSV repRNA and the membrane-bound p33 in yeast.
eEF1A binds to the silencer sequence in the 3′ UTR of the TBSV repRNA
Human and plant eEF1A is known to bind to the 3′ UTR of several
RNA viruses in vitro (Blackwell and Brinton, 1997; Dreher, 1999). To
test if the 3′ UTR of the TBSV RNA is also bound to eEF1A, we made a
32P-labeled RNA probe containing the conserved three 3′ terminal
stem–loops in the TBSV RNA, termed SL1, SL2 and SL3 (Na and White,
2006). Gel mobility shift assay with puriﬁed recombinant eEF1A
revealed binding to theWT SL1/2/3 sequence (Fig. 7A, lanes 2–4). A G-
to-Cmodiﬁcation at the 3′ terminus in construct SL1/2/3 that weakens
Fig. 7. Binding of eEF1A to the replication silencer sequence of the TBSV (+)repRNA invitro. (A) Gelmobility shift assaywasperformedwith the 32P-labeledWTandmutatedSL1/2/3(+) RNA
probe. The SL1/SL2/SL3 sequence represents the 86 nt 3′ terminal, highly structured sequence of the TBSV (+)RNAwith two known cis-acting elements: the replication silencer element
required for the assembly of the viral replicase and gPR that is an essential promoter for initiation of minus-strand synthesis and it is also required for replicase assembly. The mutated/
deletedbasesare indicatedwithblackor grayboxes. The recombinanteEF1Apuriﬁed fromyeast asGST-fusionproteinwas tested in threedifferent dilutions:2.0, 0.8 and0.4 μg. (B)Template
competition assay to test the binding of eEF1A to the viral template. Gel mobility shift assay was performed with the 32P-labeledWT-SL1/SL2/SL3(+) RNA probe and puriﬁed eEF1A (as in
panel A), whereas the unlabeled competitor RNAwas used in 5×, 20× and 100× excess over the labeled one as shown. Template gPR-CCC-UUU(+) has the 3′ terminal three Cs changed to
threeUs (not shown). Lane1 shows themigration of the free SL1/2/3 probewithout eEF1A,whereas lane 2 shows the band-shift causedby eEF1Abinding in the absenceof competitor RNA.
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gPR and SL3, which is critical for the assembly of the replicase
(Panaviene et al., 2005), did not change the binding to eEF1A in vitro
(Fig. 7A, lanes 6–8). On the contrary, deletion of 5 nt within a known
cis-acting element, termed replication silencer element (RSE) (Pogany
et al., 2003), inhibited binding to eEF1A (Fig. 7A, lanes 9–12). This
deletion is within an 8 nt long internal loop and is not expected to
change the structure of SL3 dramatically, albeit it destroys the middle-
range interaction between SL3 and gPR, which includes SL1 (see the
WT construct in Fig. 7A) (Pogany et al., 2003). Template competition
experiments with unlabeled competitors conﬁrmed the above results,
since construct SL1/2/3ΔGGGCU(+) lacking 5 nt of the RSE element
was a poor competitor when compared with the wt and other RNAs
carrying mutations within the gPR sequence (Fig. 7B). Altogether,these data indicate that eEF1A binds to RSE, an important cis-acting
element involved in the assembly of the tombusvirus replicase
(Panaviene et al., 2005).
A mutation affecting guanine exchange factor (GEF) requirement of
eEF1A inhibits TBSV repRNA accumulation in yeast
To obtain additional functional relevance for eEF1A in tombusvirus
replication, we utilized a strainwhere the only form of eEF1A contains
a 6xHis tag and is expressed from a copper repressible promoter
(TKY616) (Anand et al., 2006). Indeed, the level of eEF1A decreased by
∼40% in TKY616 strain 12 h after addition of copper to the growth
media (Fig. 8C, lanes 4–6 versus 1–3). Northern blot analysis revealed
that the accumulation of TBSV repRNA decreased to 39% of that
252 Z. Li et al. / Virology 385 (2009) 245–260present in the WT strain (Fig. 8A). The expression level of p33
replication protein also decreased (Fig. 8B), suggesting that either the
translation or the stability of p33was reduced in the presence of lower
level of eEF1A.
To further analyze the role of eEF1A in TBSV replication, we assayed
a bank of eEF1Amutants (Carr-Schmid et al., 1999; Dinman and Kinzy,1997; Gross and Kinzy, 2005, 2007; Ozturk et al., 2006). The 22 eEF1A
mutants belong to four groups based on their mapped functions as
speciﬁed in Table 2. The mutations decrease translation ﬁdelity, have
altered requirement for the guanine nucleotide exchange factor
eEF1Bα encoded by the TEF5 gene, or show reduced binding to actin
(Table 2). These strains lack the chromosomal TEF1 and TEF2 genes
and eEF1A is expressed from a centromeric plasmid under the control
of the native TEF promoter.
Out of 22 eEF1Amutant strains tested for the accumulation of TBSV
repRNA, we found that only TKY848 (T22S) reduced TBSV RNA level
signiﬁcantly (down to 26%, Fig. 8D, lanes 5–8 and Table 2). Western
blot analysis of replication protein levels in the TKY848 (T22S) strain
revealed that the p92pol was expressed at a level comparable to the
WTeEF1A strain (Fig. 8E), while p33 level was reduced to 33% (Fig. 8F).
These data suggested that eEF1A (T22S) selectively reduced p33 levels,
but not that of p92pol. Northern blotting of p33 mRNA transcribed
from an expression plasmid revealed comparable levels in yeast
strains expressing either eEF1A (T22S) or WT eEF1A (Fig. 8G),
excluding the possibility that RNA transcription is the reason for
reduced level of p33 in eEF1A(T22S) yeast.
Because eEF1A is a translation factor, it is possible that translation
of p33 from the p33 mRNA is selectively inhibited by T22S mutation.
To test this possibility, we have adapted a yeast cell-free translation
assay that can be programmed with externally added mRNA
transcripts (Materials and methods). The in vitro translation assay
prepared from yeast strains expressing either WT eEF1A or eEF1A
(T22S) supported the production of comparable levels of p33 and the
control MS2-CFP (Fig. 8H) from the added mRNAs, suggesting that the
T22S mutation in eEF1A did not affect the translation of p33.
eEF1A(T22S) reduces the half-life of p33 replication co-factor in yeast
Since production of p33 is not affected by eEF1A(T22S), we also
tested the half-life of p33 in yeast expressing either eEF1A(T22S) or
WT eEF1A after the shut down of protein synthesis by cycloheximide.
The steady-state level of p33 was measured with Western blotting in
samples obtained at various time points from yeast strains expressing
either eEF1A(T22S) or WT eEF1A. These experiments have demon-
strated that the half-life of p33 was reduced to ∼130 min in yeast
expressing eEF1A(T22S) (Fig. 9, lanes 1–8) from over 330 min in yeast
expressing WT eEF1A (Fig. 9, lanes 9–15). Thus, eEF1A is likely
involved in stabilization of p33 replication cofactor in yeast.
Discussion
RNA-binding proteins of the host likely play multiple roles during
the replication of RNA viruses. They might affect (i) translation of the
viral RNA, (ii) RNA template selection by viral replication proteins, (iii)Fig. 8. The effect of eEF1A on TBSV repRNA accumulation and on the replication
proteins. (A) The expression of eEF1A protein was down-regulated from a copper-
repressible promoter in TKY616. Replication of the TBSV repRNA was measured by
Northern blotting 12 h after initiation of TBSV replication and suppression of eEF1A
expression. (B) Accumulation of p33 and (C) eEF1A was estimated by Western blotting
using anti-His and anti-eEF1A antibodies, respectively. (D) Reduced accumulation of
TBSV repRNA in TKY848 yeast expressing eEF1A(T22S) as the only form of eEF1A 24 h
after induction of TBSV repRNA replication. The TBSV repRNA and 18S ribosomal RNA
levels were estimated by Northern blotting. RecRNA shows novel recombinant RNAs
derived from TBSV repRNA and characterized earlier (Cheng et al., 2006). (E)
Accumulation of p92pol and (F) p33 was estimated by Western blotting using anti-His
antibody in TKY848 and TKY102 yeast strains. (G) The production of p33mRNA from an
expression plasmid was estimated by Northern blotting using p33 mRNA-speciﬁc
probe. (H) Translation of p33 in extracts prepared from TKY848 and TKY102 yeast
strains. The in vitro translation assay of p33 from an exogenously added mRNA in the
presence of 35S methionine was performed with extracts containing comparable
amounts of yeast proteins. Samples were taken at various time points as shown. Bottom
panel: Translation of MS2-CFP from an exogenously added mRNAwas used as a control.
The band at the bottom of both gels represents the dye front.
Table 2
The effect of eEF1A mutations on TBSV repRNA accumulation
Strain Mutation Effect on eEf1A function repRNA accumulation5 p33 level6
TKY1021 WT One copy of TEF (tef1Δ) 100.0±21.8 100
TKY1111 E317K Translational misreading: increased +1 ribosomal frameshifting 59.4±12.5 93
TKY1121 E40K Translational misreading: increased +1 ribosomal frameshifting 60.1±11.0 82
TKY1131 E122K Translational misreading: increased −1 ribosomal frameshifting 53.3±11.2 78
TKY1141 T142I Translational misreading: increased +1 ribosomal frameshifting 69.4±23.0 78
TKY1151 E295K Translational misreading: increased −1 ribosomal frameshifting 117.6+26.8 68
TKY1161 E122Q Translational misreading: increased −1 ribosomal frameshifting 59.6±15.8 79
TKY1171 D130N Translational misreading: increased −1 ribosomal frameshifting 64.0±16.3 81
TKY2782 D156N Decreased translation ﬁdelity/GTP-binding site mutant 64.5±16.0 72
TKY2802 N153T Decreased translation ﬁdelity/GTP-binding site mutant 117.9+74.0 89
TKY2822 N153T Decreased translation ﬁdelity/GTP-binding site mutant 126.6+38.5 85
D156E
TKY7893 R164K GEF independent growth, mutation in nucleotide binding domain 106.0+25.0 85
TKY7913 A117V GEF independent growth, mutation in nucleotide binding domain 120.2+38.8 73
T172A
TKY8463 D156E GEF independent growth, mutation in nucleotide binding domain 90.1±34.4 91
TKY8473 D156N GEF independent growth, mutation in nucleotide binding domain 71.9±5.2 86
TKY8483 T22S Increased nonsense suppression/GEF independent growth 26.6±6.3 33
TKY8493 A112T Increased nonsense suppression/GEF independent growth 85.5±18.5 85
TKY8503 E122K GEF independent growth, mutation in nucleotide binding domain 98.2±13.3 82
TKY8513 A117T GEF independent growth, mutation in nucleotide binding domain 103.9±15.1 84
TKY8523 A117V GEF independent growth, mutation in nucleotide binding domain 142.7±22.7 84
TKY8964 WT One copy of TEF 100.0±18.0 100
TKY8984 K333E Reduced binding to actin 120.0±31.0 113
TKY9014 F308L Reduced binding to actin, reduced translation initiation 104.0±20.0 111
TKY9034 S405P Reduced binding to actin, reduced translation initiation 104.0±29.0 147
1 Based on ﬁve samples analyzed via Northern blotting, as described in Fig. 8D.
2 Based on Western blotting, as described in Fig. 8F.
3 Dinman and Kinzy (1997).
4 Carr-Schmid et al. (1999).
5 Ozturk et al. (2006).
6 Gross and Kinzy (2007).
253Z. Li et al. / Virology 385 (2009) 245–260recruitment of the viral RNA for replication, (iv) RNA synthesis, and/or
(v) RNA stability (Ahlquist et al., 2003; Brinton, 2001; Cristea et al.,
2006; Nagy, 2008; Nagy and Pogany, 2006; Shi and Lai, 2005). A
proteome-wide approach using the yeast protein array allowed us to
test ∼70% of all yeast proteins for their abilities to bind to viral RNAs
(TBSV or BMV). Among the 57 host proteins that bound signiﬁcantly to
viral RNAs (either TBSV or BMV), thirty are known RNA-binding
proteins, whereas the other 27 had not previously been shown to bind
to RNA (Table 1). We found eleven host proteins that bound to TBSV
RNA more selectively than to the BMV RNA, including two known
helicases (encoded by DBP2 and YFR038W), a translation initiation
factor (GCD2), and two RNAmodifying proteins, such as a pseudourine
synthase (DEG1) and one of the components of the small subunit
processosome (UTP7). The remaining six proteins include an RNA-
binding protein (SRP40), a membrane-targeting protein (SEC62), an
aminopeptidase (MAP1) and three proteins of unknown function
(YNL196C, YFR042W, YPR174C).
Among the seven identiﬁed host proteins that bound to BMV RNA
more efﬁciently than to the TBSV RNA, there are two proteins known
to bind to tRNAs (DPS1 and ARC1) (Table 1). The 3′ ends of the BMV
RNAs form tRNA-like structures, and the BMV RNA has been shown to
bind to tRNA-speciﬁc proteins (Dreher, 1999). Moreover, the 3′ end of
the BMV RNA can be aminoacylated (Dreher, 1999), conﬁrming the
functional interaction between tRNA-modifying enzymes and the
BMV RNA. Additional genes coding for known RNA binding proteins,
which also bound to BMV RNA, include NPL3, LRP1 and BFR1 (Table 2).
The RNA binding activities of the remaining two proteins coded by
EGD1 and YHL013C genes have not been documented before.
The remaining 39 host proteins identiﬁedwith both TBSV and BMV
RNA probes are involved in a variety of cellular processes, such as
translation initiation or elongation, transcription activation, ribosomal
RNA processing/binding, mRNA transport, protein membrane target-
ing or are predicted to have various biochemical activities, such as
helicase, tRNA ligase, tRNA methyltransferase, rRNA dimethylase,ribonuclease, co-chaperone, and protein kinase (Table 1). One of these
proteins, translation elongation factor eEF1A, is the homolog of the
plant eEF1A, which has been shown to bind to the BMV RNA (Bastin
and Hall, 1976). In addition, the identiﬁed pseudouridine synthase
Pus4p (Table 1) could be involved in pseudouridynylation-based
modiﬁcation of BMV RNA, which has been shown to occur in vivo
(Baumstark and Ahlquist, 2001). Interestingly, Pus4p has also been
identiﬁed in a similar screen with a unique yeast protein array using a
3′ end cis-acting element from BMV RNA (Zhu et al., 2007).
To validate the protein array approach for identiﬁcation of RNA
binding proteins, we demonstrated that several recombinant yeast
proteins bound toTBSV RNA in a gel mobility shift assay (Fig. 2 and not
shown) and via co-puriﬁcation from yeast cells (Fig. 3). The data
obtained support the idea that a number of RNA-binding proteins
from yeast likely interact with the TBSV (+)RNA. We found that many
of the identiﬁed host RNA binding proteins affected TBSV repRNA
replication, conﬁrming their relevance. For example, Dbp2p, Gcd2p,
Stm1p and Mdm38 enhanced TBSV repRNA accumulation, while 14
proteins out of 45 yeast proteins tested decreased TBSV repRNA
accumulation by 2.5–10-fold in a protein over-expression assay (Figs.
4A–B). Based on these data, it is likely that 18 of the tested host RNA
binding proteins (Figs. 4 and 5) interact with the TBSV repRNA in vivo,
whereas the functional relevance of the remaining 27 host proteins
requires further analysis.
Two yeast proteins among the stimulators of replication when
over-expressed are involved in translation or degradation of mRNAs.
Gcd2p is the delta subunit of the translation initiation factor 2B
(eIF2B), the guanine nucleotide exchange factor for eIF2. Dbp2p is a
homolog of the human p68 (Iggo et al., 1991) and the Arabidopsis
AtDrh1p (Okanami et al., 1998), known RNA helicases that could be
involved in nonsense-mediated mRNA decay, rRNA processing and
replication of Hepatitis C virus (Bond et al., 2001; Goh et al., 2004). We
propose that Gcd2p and Dbp2p could facilitate the recruitment of the
viral RNA into replication (via inhibiting translation of the genomic
Fig. 9. Reduced half-life of p33 in TKY848 yeast strain. (A) Translation of mRNAs was stopped in yeast with cycloheximide, followed byWestern blot analysis of p33 levels with anti-
His antibody at various time points. Strain TKY102 expressing WT eEF1A was used as a control. (B) Calculation of the half-life of p33 in TKY848 and TKY102. The experiments were
repeated three times and the standard deviation is shown.
254 Z. Li et al. / Virology 385 (2009) 245–260RNA) or promoting the assembly of the viral replicase complex prior to
replication. Also, Dbp2p might enhance replication via interacting and
inhibiting Nog1p, a putative GTPase, whose down-regulation led to
increased TBSV repRNA accumulation in yeast (Jiang et al., 2006). It is
less straightforward to propose a model for the activity of Mdm38p,
which is a mitochondrial membrane protein with no known RNA-
binding activity (Table 2). Mdm38p might facilitate TBSV RNA
accumulation via a novel function.
The identiﬁed 14 yeast proteins inhibiting tombusvirus accumula-
tion when over-expressed might interfere with the recruitment of the
viral RNA into replication, or the assembly of the viral replicase
complex prior to replication. Alternatively, they could also increase
the degradation of the viral RNA (e.g., Rny1p ribonuclease, and Utp7p,
which is part of the processosome).
eEF1A is a newly identiﬁed component of the tombusvirus replicase
complex
Eukaryotic viral RNA replicases contain viral- and host-coded
components. Previous proteomic approaches with highly puriﬁed
tombusvirus replicase or using the yeast protein array have led to the
identiﬁcation of four host proteins that are integral components of the
tombusvirus replicase complex: the heat shock protein 70 chaperones
(Ssa1/2p in yeast), glyceraldehyde-3-phosphate dehydrogenase
(GAPDH, encoded by TDH2 and TDH3 in yeast), pyruvate decarbox-
ylase (Pdc1p) and Cdc34p E2 ubiquitin-conjugating enzyme (Li et al.,
2008; Serva and Nagy, 2006;Wang and Nagy, 2008). The current work
establishes that eEF1A is also an integral part of the replicase complex.
Replicase puriﬁcation experiments with or without protein cross-
linking conﬁrmed the presence of eEF1A (Fig. 5). In addition, we have
shown that eEF1A can bind to the TBSV repRNA in vitro as well as the
TBSV repRNA can be co-puriﬁed with eEF1A from yeast (Fig. 3).Moreover, eEF1A has been shown to interact with the p33 replication
co-factor based on the yeast split-ubiquitin two-hybrid assay (Fig. 6).
Interestingly, eEF1A has also been shown to bind to the non-
overlapping portion of the p92pol RdRp protein in vitro based on
yeast protein array experiments (Li et al., 2008). Thus, the accumulat-
ing evidence shows that eEF1A interacts with components of the
tombusvirus replicase, including repRNA, p33 and p92pol replication
proteins. It is also interesting that eEF1A has been shown to interact
with the yeast Tdh2p (GAPDH) (Gavin et al., 2006), which is also a
component of the tombusvirus replicase. Overall, the multiple
interactions of eEF1A with various components of the tombusvirus
replicase could be important for eEF1A to regulate the functions of the
viral replicase complex.
eEF1A is a highly abundant protein with the canonical role of
delivering aminoacyl-tRNA to the elongating ribosome in a GTP
dependent manner. Many additional functions have been ascribed to
eEF1A including quality control of newly produced proteins, ubiqui-
tin-dependent protein degradation, and organization of the actin
cytoskeleton (Chuang et al., 2005; Gross and Kinzy, 2005). The ﬁrst
evidence that a translation elongation factor plays a role in (+)RNA
virus replication was obtained with bacteriophage Qbeta (Blumenthal
et al., 1976). Subsequently, eEF1A was found to bind to many viral
RNAs (Dreher, 1999). The list includes the 3′ UTR of (+)RNA of West
Nile virus (WNV) based on nitrocellulose ﬁlter binding assays and
RNase footprinting (Blackwell and Brinton, 1997; Brinton, 2001). This
is supported by functional data, since mutations in the eEF1A binding
site of WNV RNA decreased minus-strand synthesis and eEF1A is co-
localized with the WNV replicase in the infected cells (Davis et al.,
2007). Similarly, eEF1A was shown to bind to the 3′ end of Turnip
yellow mosaic virus (+)RNA leading to enhanced translation but
repressed minus-strand synthesis (Dreher, 1999; Dreher et al., 1999;
Matsuda et al., 2004). In addition, eEF1A was reported to bind to
255Z. Li et al. / Virology 385 (2009) 245–260Dengue virus, Tobacco mosaic virus and Turnip mosaic virus (+)RNA (De
Nova-Ocampo et al., 2002; Nishikiori et al., 2006; Thivierge et al.,
2008; Zeenko et al., 2002). eEF1A has also been shown to interact with
various viral replication proteins or the replicase as shown for the
NS5A replication protein of BVDV (Johnson et al., 2001), NS4A of HCV
(Kou et al., 2006), the TMV replicase (Yamaji et al., 2006), and Gag
polyprotein of HIV-1 (Cimarelli and Luban, 1999). It is also part of the
replicase complex of vesicular stomatitis virus, a negative-stranded
RNA virus (Qanungo et al., 2004). Overall, eEF1A likely plays a role in
the replication of several RNA viruses via its interactions with viral
RNAs and viral replication proteins. The high abundance of eEF1A in
cells might facilitate its recruitment into virus replication.
eEF1A affects TBSV repRNA accumulation by stabilizing p33 replication
cofactor in yeast
Since eEF1A is an essential G protein affecting translation
elongation, it is very difﬁcult to obtain evidence for its direct
involvement in virus replication in living cell. Accordingly, down-
regulation of eEF1A has led to not only decreased TBSV repRNA
accumulation, but also reduced p33 levels (Figs. 8A–C). However,
using functional eEF1A mutants defective in various functions and
domains could potentially lead to identiﬁcation of functions provided
by eEF1A during TBSV repRNA replication in yeast. In this work, we
have used four different groups of eEF1A mutants (Table 2). The most
interesting mutant was eEF1A(T22S), which has mutation within the
P-loop leading to decreased binding of eEF1A to GDP (Ozturk et al.,
2006). This mutation renders eEF1A functionally independent of its
guanine nucleotide exchange factor eEF1Bα. We found that eEF1A
(T22S) supported TBSV repRNA replication only at ∼26% level when
compared with theWTeEF1A (Fig. 8D). Interestingly, yeast expressing
eEF1A (T22S) displayed normal levels of p92pol, but reduced levels of
p33 replication protein (Figs. 8E–F). Since eEF1A (T22S) is known to
reduce total translation level by 35% and decrease translational ﬁdelity
(Ozturk et al., 2006), we tested if eEF1A (T22S) affected p33 translation
using an in vitro assay (Fig. 8H). However, the translation level of p33
was comparable in extracts prepared from yeast expressing either WT
eEF1A or eEF1A(T22S). Thus, it is unlikely that eEF1A (T22S) would
affect p33 level through its effect on general translation. More
importantly, the half-life of p33 was reduced by more than 2-fold in
yeast expressing eEF1A(T22S), suggesting that eEF1A is involved in
stabilization of p33 in yeast.
The eEF1A mutants deﬁcient in interaction with actin had no
major effect on TBSV repRNA accumulation, suggesting that the
ability of eEF1A to interact with actin ﬁlaments/patches might not be
critical for TBSV replication in yeast. Several mutations in the GTP-
binding domain or that decreased translational ﬁdelity had 30–50%
inhibition of TBSV repRNA accumulation (Table 2). However, other
mutants with similar characteristics have not inhibited TBSV repRNA
accumulation. Altogether, the use of eEF1A mutants revealed that
eEF1A is involved in stabilization of p33 replication protein in yeast.
Future work will dissect the regions of eEF1A to identify domains or
functions required for TBSV replication.
Usefulness and limitation of the protein array approach in identiﬁcation
of host proteins binding to viral RNAs
One of the surprising observations is that most of the yeast RNA-
binding proteins identiﬁed in this work were not identiﬁed in
previous screens with the YKO and yTHC libraries (Jiang et al., 2006;
Kushner et al., 2003; Panavas et al., 2005b; Serviene et al., 2006,
2005). The only exception is BUD21(UTP16), whose deletion
increased replication of TBSV repRNA (Panavas et al., 2005b). It is
possible that many genes involved in TBSV repRNA replication and
recombination are functionally redundant. Indeed, the host proteins
that were identiﬁed in a highly puriﬁed functional tombusvirusreplicase complex (such as Ssa1/2p and Tdh2/3p) (Serva and Nagy,
2006) and eEF1A (this work) are coded by two or more genes in the
yeast genome. This functional redundancy in host genes justiﬁes
the need for multiple genome- or proteome-wide approaches in
the identiﬁcation of host genes affecting TBSV replication and
recombination.
The above protein array-based approach led to the identiﬁcation of
two known BMV RNA binding host proteins (i.e., eEF1A and Pus4p)
(Bastin and Hall, 1976; Zhu et al., 2007). However, this approach failed
to identify Ded1p and Lsm1p, two known RNA-binding proteins that
affected BMV replication in yeast (Diez et al., 2000; Noueiry and
Ahlquist, 2003). Ded1p selectively inhibits the translation of 2a
protein from RNA2, whereas we used RNA1 in our experiments, which
might bind inefﬁciently to Ded1p. It is also possible that some proteins
are not functional in RNA-binding when ﬁxed on the chip. Alter-
natively, the interaction between the host protein and the viral RNA
could be facilitated by additional factors, such as the 1a replication
protein of BMV, which were not present in our in vitro analysis. The
Lsm1p-like proteins are known to formmultimeric, doughnut-shaped
complexes (Noueiry and Ahlquist, 2003), and this screen would likely
miss any protein that acts in a heteromeric complex. In addition, the
protein array contains only ∼70% of the known/predicted number of
proteins expressed in yeast. The above examples highlight the
possibility that our current work is likely an under estimation of the
number of host proteins that bind to viral RNAs. Regardless of these
limitations, the protein array approach could provide a rapid tool for
identiﬁcation or conﬁrmation of RNA binding host proteins.
Materials and methods
Yeast strains and expression plasmids
Saccharomyces cerevisiae strain BY4741 (MATa his3Δ1 leu2Δ0
met15Δ0 ura3Δ0) was obtained from Open Biosystems (Huntsville,
AL, USA). Plasmid-borne TEF1/2 TKY strains (MATα ura3-52 leu2-3, 112
trp1-Δ1 lys2-20 met2-1 his4-713 tef1::LEU2 tef2Δ pTEF2 URA3) were
published before (Carr-Schmid et al., 1999; Dinman and Kinzy, 1997;
Gross and Kinzy, 2007; Ozturk et al., 2006).
To study the effect of over-expression of selected yeast proteins on
viral RNA replication and recombination, we used the yeast ORF
collection from Open Biosystems (Huntsville, AL, USA), in which each
yeast gene ORF is expressed from 2 μ plasmid BG1805 under the
control of GAL1 promoter and fused to a tandem afﬁnity tag that
includes an HA epitope tag and the ZZ domain of Protein A at the C-
terminus (Gelperin et al., 2005).
The LEU2 expression plasmid pGAD-His92-CUP1, carrying Cucum-
ber necrosis virus (CNV) p92 gene behind the CUP1 promoter has been
described (Li et al., 2008). Construction of the HIS3 dual expression
plasmid pHisGBK-His33/DI-72-CUP1 (co-expressing CNV p33 from
the ADH1 promoter and DI-72 RNA from the CUP1 promoter) was
done by inserting DI-72 sequence including the ribozyme at the 3′ end
in pGBK-His33. Sequence of the CUP1 promoter and DI-72 plus the
ribozyme were ampliﬁed by PCR with primer pairs #1779/#1780 and
#471/#1069, respectively, followed by digestion with Xho I and
ligation of these PCR products with each other. Then, the ligation
mixture was used as template to amplify the expression cassette
CUP1-DI-72 with primers #1779/#1069, and then digested with EcoR I
and Sac I. The PCR products were recovered and ligated with pHisGBK-
His33/DI-72 treated with EcoR I and Sac I (Jiang et al., 2006), resulting
in pHisGBK-His33/DI-72-CUP1. pHisGBK-His33-CUP1/DI-AU-FP-Gal1
(co-expressing CNV p33 from the CUP1 promoter and DI-AU-FP RNA
from the GAL1 promoter and HIS3 marker) has been described (Li et
al., 2008).
To study viral replication and protein stability in the TKY102 and
TKY848 strains, we used plasmid pCM185-TET-His92 (TRP) or
pCM189-TET-His92 (URA3), both expressing 6xHis-tagged CNV p92
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CUP1-His33, expressing 6xHis-tagged CNV p33 driven by CuSO4
inducible promoter CUP1 (Jaag et al., 2007). We also generated
pESCHIS4-ADH-His33/CUP1-DI-72 (HIS4) that co-expressed 6xHis-
tagged CNV p33 and DI-72 repRNA under the control of ADH1 and
CUP1 promoters, respectively. To obtain this plasmid, the HIS4
sequence was ampliﬁed by PCR fromyeast genomic DNAwith primers
#2548 and #2549 and digested by Xma I and Sph I. Primers #2544 and
#2545 were used to amplify sequences from plasmid pESC-p33-DI72
(Pathak et al., 2008), co-expressing 6xHis-tagged CNV p33 of from the
GAL1 promoter and TBSV DI-72 repRNA from the GAL10 promoter,
without the HIS3 coding region. The resulting PCR product was
digested with Xma I and Sph I and with the HIS4 fragment to make
plasmid pESCHIS4-DI72-p33. To generate pESCHIS4-ADH-His33/
CUP1-DI-72, plasmid pESCHIS4-DI72-p33 was digested with Nco I
and Sac I and then the DNA fragment containing the plasmid backbone
sequencewas recovered. The recovered DNAwas then ligatedwith the
ADH-His33/CUP-DI-72 expressing cassette obtained with Nco I and
Xho I digestion of plasmid pHisGBK-His33/DI72-CUP1.
To study the p33–eEF1A interaction in yeast by split-Ub assay, the
TEF2 sequence was ampliﬁed with PCR using primers #1786 and
#2088, followed by digestion with BamHI and BglII and cloned into
pPR-C-RE to produce pPR-C-TEF2 (NubG) as described previously (Li et
al., 2008).
To produce recombinant yeast proteins in E. coli as maltose binding
protein (MBP) fusions (Rajendran and Nagy, 2004), the yeast genes
were ampliﬁed from the yeast genome by PCR using gene-speciﬁc
primers as shown in Table 1. The PCR products were digested with the
restriction enzymes shown in the name of the primers, followed by gel
isolation and ligation into gel-isolated pMalc-2X plasmid digested
with BamHI and SalI. In order to remove the intron from the DBP2
gene, primers #1998 and #1999 were kinased and used in combina-
tion with primers #1874 and #1875 to amplify the DBP2 sequence
upstream and downstream of the intron, respectively. The PCR
products were gel-isolated and ligated. The full-length cDNA of the
DBP2 was ampliﬁed from the above ligation reaction using primers
#1874 and #1875 and cloned into pMalc-2X plasmid as described
above. MBP fusion proteins were expressed and puriﬁed according to
(Rajendran and Nagy, 2004), except that after the last washing step,
the columns were spinned at 600 ×g for 2 min at 4 °C. Then 0.5 ml
elution buffer was added and after 5 min incubation at 4 °C, the
columns were centrifuged for 2 min at 4 °C. The eluted puriﬁed
proteins were stored at 4 °C until use.
RNA-labeling for the protein array experiments
TBSV gRNA, TBSV DI-72 RNA (uncapped) and BMV RNA1 (capped
with m7GpppG), respectively, were labeled with biotin by in vitro T7
RNA polymerase (Takara) transcriptionwith linearized plasmids using
biotin-UTP as described (Cheng and Nagy, 2003). The plasmids
carrying TBSV and BMV sequences, respectively, with T7 promoter
at the 5′ end were linearized with SmaI or EcoRI (Nagy and Bujarski,
1993;White andMorris, 1994a). In addition, the BMV RNAwas capped
with m7GpppG (Nagy and Bujarski, 1992), whereas the TBSV RNA was
uncapped, similar to natural virus infections. After the T7 transcrip-
tion, the unincorporated biotin-UTP was removed on a Qiagen mini
gel ﬁltration column. The ﬁnal RNA concentration was 200 μg/ml and
RNA quality was determined to be majority full-length products on a
1% agarose gel. The efﬁciency of biotinylation was tested using
Streptavidin MagneSphere Paramagnetic Particles (SA-PMPs). Brieﬂy,
a 20 μl suspension of SA-PMPs (Promega) was washed three times
with 300 μl of 0.5× SSC buffer and ﬁnally re-suspended in 50 μl 0.5×
SSC buffer. Biotinylated RNA (5 μl) was then added followed by 10 min
incubation at room temperaturewith occasional gentle mixing (Cheng
and Nagy, 2003). The SA-PMPs were collected on the side of the tube
with a magnetic stand. The amount of unbound RNA in the solutionwas analyzed on a 1% agarose gel showing that 90–95% of the RNAwas
bound to SA-PMPs.
Yeast protein array analysis
The Protein Array slide (Invitrogen) was blocked for 1 h at 4 °C in
the blocking buffer (1× PBS, 1.0% BSA and 0.1% Tween 20). Then, the
RNA probe for each protein array was added in 120 μl volume,
containing 20 μg of biotinylated RNA, 25 μg/ml poly dG–dC (Sigma),
1.0% BSA, 8 units of RNasin (Fermentas) in 50 mM Tris pH-8.0, 10 mM
MgCl2, 10 mM DTT, and 25 mM KCl. The slide was then covered and
incubated at room temperature for 1 h. After three 5-minwashes with
a buffer (1× PBS, 5 mM MgCl2, 0.5 mM DTT, 5% glycerol, 1.0% BSA and
0.05% Tween 20), the protein array was incubated on ice with 0.1 μg/
ml Streptavidin-Alexa Fluor 647 in the binding buffer. After centrifu-
gation for 4 min at 800 ×g, the protein array slide was left in the slide
holder to air dry. Scanning and quantiﬁcation were performed with
ScanArray 4000 (Packard Bioscience, Billerica, MA) scanner and
QuantArray V3.0 software.
TAP-based afﬁnity puriﬁcation of protein–RNA complexes
For the protein-TBSV RNA co-puriﬁcation experiments, we used
the TAP library of yeast strains, which express selected gene products
from their native promoters and in their natural chromosomal
locations (Open Biosystems, Huntsville, AL) tagged at their C-terminus
with the TAP-tag (Puig et al., 2001). The TAP tag consists of Protein A
sequence, a TEV protease cleavage site and the calmodulin binding
protein domain and afﬁnity puriﬁcation was performed as described
(Puig et al., 2001). Selected yeast strains from the TAP-library were
transformed with pYC-DI-72 to express TBSV DI-72(+) RNA from GAL1
promoter (Panavas and Nagy, 2003). The transformed strains were
grown in 3 l cultures under inducing conditions (∼1.0 OD), followed by
pelleting and homogenization in liquid nitrogen. Lysates were
resuspended in 10 ml of ice-cold IPP-150 buffer (10 mM Tris–HCl pH
8.0, 150 mM NaCl, 0.1% NP-40), followed by centrifugation for 15 min
at 30,000 ×g at 4 °C. The supernatant was loaded on a 0.2 ml IgG
agarose containing column (Sigma) followed by incubation and
washing with 30 ml of ice-cold IPP-150 buffer. Then, the column was
equilibrated with 1 ml of TEV protease cleavage buffer, followed by
addition of 10 μl of TEV protease (AcTEV protease from Invitrogen)
and incubation for 1 h at room temperature. The TAP-tagged protein
eluted in 1.2 ml TEV protease cleavage buffer was mixed with 3.5 μl of
1 M CaCl2 and added to a column containing 0.2 ml Calmodulin
beads (Stratagene). After incubation at 4 °C for 2 h, the column was
washed with 30 ml of Calmodulin Binding Buffer (10 mM Tris–HCl
pH 8.0, 1 mM magnesium acetate, 150 mM NaCl, 0.1% NP-40, 1 mM
imidazole, 2 mM CaCl2, and 10 mM β-mercaptoethanol) and the TAP-
tagged protein was eluted in 800 μl of Calmodulin elution buffer
(10 mM Tris–HCl pH 8.0, 1 mM magnesium acetate, 150 mM NaCl,
0.1% NP-40, 1 mM imidazole, 2 mM EGTA, and 10 mM β-
mercaptoethanol) (Puig et al., 2001). Half of the protein samples
were used for RNA extraction with phenol/chlorophorm 1:1 followed
by ethanol/sodium acetate precipitation (Panavas and Nagy, 2003).
The co-puriﬁed TBSV DI-72(+) RNA was detected by Northern blot
using 32P-labeled DI-72(−) RNA probe (Panavas and Nagy, 2003;
Panavas et al., 2005b). The other half of the puriﬁed samples was
used for 10% SDS-PAGE (after concentration of samples via TCA
precipitation). The gels were stained with silver and scanned
(Rajendran and Nagy, 2004).
GST-afﬁnity puriﬁcation of protein–RNA complexes from yeast
For protein–RNA co-puriﬁcation experiments, we used pHisGBK-
His33/DI-72-CUP1 (Jiang et al., 2006), which is a dual construct
expressing a p33 protein with 6xHis tag from the ADH1 promoter and
257Z. Li et al. / Virology 385 (2009) 245–260the DI-72 repRNA from the CUP1 promoter, and pGAD-His92
(Panaviene et al., 2004), which has p92 with 6xHis tag at the N-
terminus driven by the ADH1 promoter. BY4741 yeast cells were also
co-transformed with expression plasmids selected from a GST-6×His
ORF library (a generous gift from Dr. Brenda Andrews) (Sopko et al.,
2006). Transformed yeast cells were cultured in a 1 l ﬂask containing
100 ml of synthetic complete dropout medium lacking uracil, leucine
and histidine (SC-ULH−) starting at an OD600 of 0.1. The yeast cells at an
OD600 of 0.9 were then pelleted (100 mg) and re-suspended in 150 μl
GST lysis buffer (140 mM NaCl, 2.7 mM KCl, 8 mM Na2HPHO4, 1.8 mM
KH2PO4, 10% glycerol, 2 mM EDTA, 0.1% NP-40, and 10 mM beta-
mercaptoethanol) containing 1% Yeast Protease inhibitor cocktail
(YPic, Sigma) in a deep well plate on ice, containing 0.25 ml volume of
glass beads. The cells were broken by a genogrinder for 2 min at
1500 rpm. The homogenized sample was re-suspended in 0.6 ml GST
lysis buffer containing 1% YPic, andwas centrifuged at 100 ×g for 5min
at 4 °C. The supernatant was transferred to a microcentrifuge tube,
followed by centrifugation at 21,000 ×g for 10 min at 4 °C. The
supernatant was incubated with GST-afﬁnity resin for 2 h at 4 °C,
followed by 5 washes with lysis buffer and elution with 50 μl
Glutathione elution buffer (10 ml buffer containing 0.03 g glutathione
and 0.5 ml 1 M Tris, pH 8.0).
A two-step co-puriﬁcation method to identify eEF1A in the viral replicase
Yeast strain SC1 (Invitrogen) was transformed with plasmids
pGBK-33HF and pGAD-92HF or pGBK-His33 and pGAD-His92 (Serva
and Nagy, 2006) to express 6xHis/FLAG-tagged p33 and p92 or only
6xHis-tagged p33 and p92 togetherwith pYC2-DI-72 expressing DI-72
repRNA. Transformed yeast cells were cultured overnight in 15-ml
culture tubes containing 3 ml SC-UTL- with 2% glucose as carbon
source at 29 °C. Yeast cells were pelleted, washed and then inoculated
into 200 ml of SC-UTL- containing 2% galatose. Next, yeast cells were
cultured at 23 °C until reaching an OD600 of 0.8–1.0 at which cells were
pelleted, and washed once with 1 X Phosphate Buffer Saline (PBS)
buffer, then suspended in 200ml pre-chilled 1X PBS buffer, and cooled
on ice. The yeast cells were then treated with 5.5 ml of 37%
formaldehyde (1% ﬁnal concentration) and incubated for 1 h on ice
with gentle shaking. The cross-linking reaction with formaldehyde
was quenched by addition of 10 ml 2.5 M glycine (ﬁnal concentration
0.125 M). Yeast were then pelleted, washed twice with 1X PBS buffer,
and stored at −80 °C until use.
Co-puriﬁcation was done according to previously described
method with minor modiﬁcation (Serva and Nagy, 2006). Brieﬂy,
200 mg of yeast cells were re-suspended and homogenized in TG
buffer (50 mM Tris–HCl [pH 7.5], 10% glycerol, 15 mM MgCl2, and
10 mM KCl) supplemented with 0.5 M NaCl, 0.1% Nonidet P-40 (NP-
40), 10 mM β-mercaptoethanol and 1% [V/V] yeast protease inhibitor
cocktail (Sigma) by glass beads using Tallboys™ high throughput
homogenizer (Thorofare, NJ, USA) (Li et al., 2008). Unbroken cells and
debris were removed by centrifugation for 5 min at 100 ×g at 4 °C,
while the membrane fraction containing the viral replicase complex
was collected by centrifugation for 15 min at 21,000 ×g at 4 °C.
Solubilization of the membrane-bound replicase was performed in
1 ml TG buffer with 0.5 M NaCl, 1% NP-40, 5% SB3–10 [caprylyl
sulfobetaine] (Sigma), 10 mM β-mercaptoethanol, 1% [V/V] yeast
protease inhibitor cocktail and 5 mM imidazole via gentle rotation for
30 min at room temperature. The solubilized membrane fraction was
centrifuged at 21,000 ×g at 4 °C for 15 min and the supernatant was
added to 0.5 ml of ProBond™ Nickel-resin (Invitrogen) pre-equili-
brated with TG buffer supplemented with 0.5 M NaCl and 1% NP-40,
followed by gentle rotation for 1 h at 4 °C. The unbound proteins were
removed by gravity ﬂow, and the resin was washed three times with
TG buffer supplemented with 0.5 M NaCl, 1% NP-40, and 10 mM
imidazole. The bound proteins were eluted 3 times with 330 μl TG
buffer supplemented with 0.5 M NaCl, 0.5% NP-40, 500 mM imidazoleand 1% yeast protease inhibitor cocktail. For RNase treatment, 2.5 μg
RNase Awas added to the eluates. The eluates were pooled and loaded
onto 50 μl anti-FLAG M2-agarose afﬁnity resin (Sigma) pre-equili-
brated with 0.7 ml TG buffer supplemented with 0.5 M NaCl and 0.5%
NP-40. After 2 h gentle rotation at 4 °C, the unbound materials were
removed by gravity ﬂow and the afﬁnity resin in the column was
washed 5 times with 1 ml TG buffer with 0.5 M NaCl and 0.5% NP-40,
and twice with 1 ml TG buffer with 50 mM NaCl and 0.1% NP-40.
Proteins bound to afﬁnity resinwere eluted by incubation in 50 μl SDS-
PAGE sample buffer at 85 °C for 10 min and then subjected to SDS-
PAGE and western blotting with anti-His and anti-eEF1A antibodies In
order to reverse cross-linking, protein eluates were heated at 100 °C
for 20 min to reverse the cross-linking prior to SDS-PAGE.
RepRNA replication assay in yeast
To study the effect of over-expression of selected yeast proteins on
viral RNA replication and recombination, we used the S. cerevisiae ORF
collection fromOpen Biosystems (BY4741 background).We performed
the replication and recombination assays with six to eight indepen-
dent samples for each strain over-expressing a given yeast ORF as
described previously (Li et al., 2008). The parental strain (BY4741) was
co-transformed with three separate plasmids: (i) pHisGBK-His33/DI-
72-CUP1, (ii) pGAD-His92-CUP1, and (iii) one of the individual yeast
ORF clones (Open Biosystems) or pYES-NT-C (Invitrogen) as a control
using the standard lithium acetate method (Gietz and Woods, 2002).
Transformants were selected by complementation of auxotrophic
markers. Each transformed strain was inoculated into SC-ULH−
medium with 2% galactose and cultured for 20 h at 29 °C to pre-
express the given yeast ORF, and then copper sulfate (50 μM, ﬁnal
concentration) was added into media to induce the expression of p92
and DI-72 RNA from the copper-inducible CUP1 promoter. The cells
were grown further for 24 h at 29 °C after adding copper sulfate and
were harvested by centrifugation.
To study replication of the TBSV repRNA in the presence of mutant
forms of eEF1A in the TKY strains (Table 2), p92 was expressed from
pCM185-TET-His92, while p33 and the DI-72(+) repRNA were
launched from a dual-expression construct, pESCHIS4-ADH-His33/
CUP1-DI-72 from ADH1 and CUP1, respectively. Yeast cells were
grown in SC-ULTH- containing 2% glucose. CuSO4 was added to yeast
culture to ﬁnal concentration of 50 μM to induce TBSV repRNA
replication. After 40 h incubation/shaking at 29 °C, the cultures were
collected and analyzed by Northern andWestern blotting as described
below.
TBSV RNA analysis with Northern blotting
Total RNA isolation and Northern blot analysis were done as
described previously (Panaviene et al., 2004). Brieﬂy, yeast cells were
resuspended in RNA extraction buffer (50 mM sodium acetate, pH 5.2,
10 mM EDTA, 1% SDS) and water-saturated phenol. Cells were shaken
for 1 to 2 min at room temperature, followed by incubation for 4 min
at 65 °C and then on ice for 5 min. After removal of phenol, the RNA
was recovered by precipitation with ethanol. The RNA samples were
separated by 1.5% agarose gel electrophoresis and were transferred to
a Hybond-XL membrane (Amersham). Northern blotting was done as
described (Panavas and Nagy, 2003). For the replication assay, RNA
hybridization was done with a mixture of two probes to detect DI-72
(+)RNA and 18S yeast ribosomal RNA (rRNA) as described previously
(Panavas et al., 2005b). For the recombination assay, we used 32P-
labeled DI-72 RIII/IV (−) probe [speciﬁc to DI-72 (+)], which was
obtained by in vitro transcription with T7 RNA polymerase on PCR
template. PCR was performed with primers #1165 and #22 on DI-72
template. The 18S rRNA probes were prepared by T7 transcription
from PCR products ampliﬁed from the yeast genomic DNA with
primers #1251 and #1252. Hybridization signals were detected using
Table 3
The names and sequences of primers used to make recombinant protein expression




































a Restriction enzyme sites are shown bold-faced.
b T7 promoter sequence is underlined.
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ImageQuant software.
Split-Ub yeast two-hybrid assay
The split-Ub assay was done on the basis of Dualmembrane kit 3
(Dualsystems Biotech) with modiﬁcation (Li et al., 2008). Brieﬂy, yeast
strain NMY51 [MATa his3Δ200 trp1-901 leu2-3,112 ade2 LYS2::(lexAop)
4-HIS3 ura3::(lexAop)8-lacZ ade2::(lexAop)8-ADE2 GAL4; Dualsystems]
was transformed with pGAD-BT2N-His33, expressing 6xHis-tagged
p33 with LexA-VP16-Cub fusion at the N terminus, and pPR-C-TEF2
(NubG), expressing eEF1A with C-terminus NubG fusion (Li et al.,
2008). The yeast transformation mixture was plated onto SC media
without tryptophan and leucine (SC-TL−) to select the transformed
plasmid. After 2–3 days, colonies were resuspended in 100 μl water,
spread onto SC media lacking tryptophan, leucine, histidine and
adenine (SC-TLHA−) plates and grown at 29 °C for 3–5 days.
Gel mobility shift assay (EMSA)
EMSAwas performed as described previously (Pogany et al., 2005),
except that the binding reaction was done in the presence of 10 mM
Tris pH 7.5, 50 mM NaCl, 1 mM DTT, 1 mM EDTA 5% glycerol, 6 U of
RNasin and 0.1 μg tRNA in a 10 μl reaction. We used 5 ng 32P-labeled
probe of DI-72(+) repRNA, whereas the puriﬁed recombinant yeast
proteins were used in three different dilutions (2.0, 0.6 and 0.2 μg).
To study the binding of eEF1A to the 3′ end of TBSV repRNA, we
made the cDNA template of the 3′ terminal 86-bp sequence from DI-
72 (+) repRNA by PCR using DI-72XP as a template (White and Morris,
1994a). For ampliﬁcation of the WT-SL1/2/3 sequence, we used
primers #1662 and #1190. For ampliﬁcation of gPR-G4-C sequence,
primer pair of #1662 and #343 was used to introduce a G to C
mutation in the genomic promoter sequences. Construction of the
SL1/2/3ΔGGGCU was done by using a DI-72XP derivative plasmid
carrying GGGCU deletion in SL3 (Pogany et al., 2003) as a template for
PCR with primers #1662 and #1190. The #1662 primer also included
the T7 promoter sequences (underlined in Table 3) to facilitate
synthesis of RNA probes. The RNA transcripts were quantiﬁed by UV
spectrophotometry (Beckman). EMSA was performed in a 10 μl-
reaction containing 20 mM HEPES [pH 7.6], 50 mM KCl, 2 mM MgCl2,
1 mM DTT, 0.1 mM EDTA, 10% [vol/vol] glycerol, 0.1 μg tRNA, 10 U of
RNase inhibitor, 10 nM RNA probe (Rajendran and Nagy, 2003) and
three different dilutions of puriﬁed GST-eEF1A (Tef2p) protein (0.4, 0.8
and 2.0 μg). GST-eEF1A was puriﬁed from yeast as described above.
Reactions were incubated at room temperature for 20 min and then
resolved in 5% nondenaturing polyacrylamide gel as described
previously (Rajendran and Nagy, 2003).
In vitro translation using a yeast soluble cell extract
Preparation of the yeast extract supporting translation in vitro was
performed as described (Iizuka and Sarnow, 1997). Yeast cells were
cultured in 350 ml YPD media at 29 °C for 15–17 h with shaking. Cells
were harvested when they reached an OD600 of 1.0, followed by
centrifugation at 5000 rpm for 4 min at 4 °C. The pelleted cells were
resuspended in 10 ml ice-cold sterile dH2O by vortexing, followed by
centrifugation at 4000 rpm at 4 °C for 4 min in a swinging bucket
rotor several times. The cells were resuspended in ice cold breaking
buffer using 2.5 ml breaking buffer per 3 g of yeast (Iizuka and
Sarnow, 1997) plus 7 μl 1 M DTT and 10 g ice cold glass beads. Yeast
cells were broken manually by shaking the tube 10 times for 30 s,
followed by centrifugation at 5000 rpm at 4 °C for 5 min in a swinging
bucket rotor. The supernatant (∼2.5 ml) was transferred to micro-
centrifuge tubes, followed by centrifugation at 21,000 ×g at 4 °C for
5 min. The supernatant was loaded onto a prechilled Sephadex
column. The active fractions (500 μl) were collected and 50 μl of thesolubile extract was treated with Micrococcal nuclease (0.5 μl of
100 mM CaCl2 and 0.75 μl microccoccal nuclease) at room
temperature for 5 min. Then, 1.5 μl of 100 mM EGTA pH 8.0 and
0.8 μl RNase inhibitor were added.
The in vitro translation reactions used 4 μl micrococcal nuclease
treated yeast soluble cell extract in 8 μl total volume also containing
1.36 μl translation mix, 0.8 μl sterile dH2O, 0.25 μl amino acid mix
withoutmethionine (1mM, Promega), 0.08 μl 35Smethionine (10mCi/
ml), 0.2 μl RNasin, and 0.3 μl creatine kinase (10 mg/ml). The assay also
contained 1 μl m7GpppG-capped RNA transcript. After 1 h incubation
at room temperature, 4 μl of 3× SDS-PAGE loading dye was added,
followed by treatment at a 100 °C for 2 min and analysis on an SDS-
PAGE gel.
Protein stability assay in yeast
Yeast strains TKY102 and TKY848 were transformed with plasmid
pGBK-CUP1-His33 expressing 6xHis-tagged CNV p33 from the
inducible CUP1 promoter. Yeast transformants were cultured in SC
media lacking tryptophan with 2% glucose at 29 °C until reaching
OD600 0.8–1.0. To induce the expression of p33, 50 μM CuSO4 was
added to the yeast cultures for 1 h at 29 °C, followed by the addition of
Cycloheximide to a ﬁnal concentration of 100 μg/ml to inhibit protein
synthesis. Equal amounts of yeast cells were collected at 0, 30, 60, 90,
150, 210, 270 and 330 min time points, and cell lysates were prepared
by NaOH method as described previously (Panavas and Nagy, 2003).
The total protein samples were analyzed by SDS/PAGE and Western
blotting with anti-His antibody (Amersham).
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